Articles Submitted
Maynard S., Gill K.J., Campbell E., Boodhoo K., Gauthier G., Xenocostas S., Charney D.A. (submitted 2015). From policy to practice: a look at the implementation of Québec’s frontline prevention program for substance use. Submitted to Healthcare Policy
Gill KJ, Hamdullahpur K (submitted 2014) A Critical Review of Heroin-Assisted Treatment: Evidence versus Ideology. Submitted to Addiction.
Articles in Refereed Journals
Charney, D. A., Heath, L. M., Zikos, E., Palacios-Boix, J., Gill, K. J. (in press). Poorer drinking outcomes with citalopram treatment for alcohol dependence: A randomized, double-blind, placebo-controlled trial. Alcoholism: Clinical and Experimental Research.
Gill, K. J., Heath, L. M., Derevensky, J., Torrie, J. (2015). The social and psychological impacts of gambling in the Cree communities of Northern Quebec. Journal of Gambling Studies. doi:10.1007/s10899-015-9553-y
Coupland S, Fraser R, Palacios-Boix J, Charney DA, Negrete JC, Gill KJ (2014) Illicit and Prescription Opiate Dependence: The Impact of Axis II Psychiatric Comorbidity on Detoxification Outcome, Journal of Substance Abuse Treatment, S10:008. DOI: 10.4172/2155-6105.S10-008
Gill KJ, Campbell E, Gauthier G, Xenocostas S, Charney D, Macaulay AC, and other members of the CIHR Team in Substance Abuse Treatment (2014) From policy to practice: implementing frontline community health services for substance dependence–study protocol. Implementation Science, 9: 108. DOI:10.1186/s13012-014-0108-x
Mauger S, Fraser R, Gill KJ (2014) Utilizing buprenorphine-naloxone to treat illicit and prescription opioid dependence, Neuropsychiatric Disease and Treatment. 10: 587-598.
Kmiotek, E. K., Baimel, C., Gill, K. J. (2012) Methods for Intravenous Self-Administration in a Mouse Model. J. Vis. Exp., e3739, DOI: 10.3791/3739
Ducharme S, Fraser R, Gill KJ (2012) Update on the clinical use of Buprenorphine in opioid-related disorders. Canadian Family Physician, 58: 37-41.
Gauthier G, Palacios-Boix J, Charney DA, Negrete JC, Pentney H, Gill KJ. (2011) Brief intervention and conventional treatment in an outpatient substance dependence treatment program: Implications for primary health care settings. Canadian Journal of Community Mental Health, 30: 93-104.
Gill KJ (2010). Les Impacts Sociaux et Psychologiques Des Jeux De Hazard Parmi Les Cries Du Québec. (The Social and Psychological Impact of Gambling in the Cree Communities of Northern Québec). Report for the Programme des Actions concertées - Impacts socioéconomiques des jeux de hasard et d'argent, Fonds québécois de recherche sur la société et la culture (FQRSC), Montréal, Québec.
Zikos E, Gill KJ, Charney D (2010) Personality disorders among alcoholic outpatients: Prevalence and course in treatment. Canadian Journal of Psychiatry, 55(2): 65-73.
Charney D, Zikos E, Gill KJ. (2010) Early recovery from alcohol dependence: Factors that promote or impede abstinence. J Substance Abuse Treatment, 38: 42-50.
Boyle AEL, Gill KJ. (2009) A verification of previously identified QTLs for cocaine-induced activation using a panel of B6.A chromosome substitution strains (CSS) and A x B6 F2 mice. Psychopharmacology, 207: 325-334.
Dranitsaris, G., Selvy, P., Negrete, JC. (2009) Meta-Analyses of Placebo-Controlled Trials of Acamprosate for the Treatment of Alcohol Dependence. Journal of Addiction Medicine, 3(2): 74-82.
Nishikawa M, Diksic M, Sakai Y, Kumano H, Charney D, Palacios-Boix J, Negrete JC, Gill KJ. (2009) Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography (PET). Alcoholism: Clinical Experimental Research, 33: 233-239.
Boyle AEL, Gill KJ. (2009) Genetic analysis of the psychostimulant effects of nicotine in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors. Mammalian Genome, 20: 34-42.
Boyle AEL, Gill KJ. (2008) Confirmation of provisional quantitative trait loci for voluntary alcohol consumption: genetic analysis in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors. Pharmacogenetics and Genomics, 18: 1071-1082.
Gill KJ, Boyle AEL.(2008) Genetic influences on drug-induced psychomotor activation in mice. Genes, Brain & Behavior, 7: 859-868.
Malat, J., Leszcz, M., Negrete, JC., Turner, N., Toneatto, T., Collins, J., Liu, E. (2008) Interpersonal Group Psychotherapy for co-morbid Alcohol Dependence and non-psychotic Psychiatric Disorders. American Journal on Addictions, 17: 402-407.
Charney D, Palacios-Boix J, Gill K. (2007) Sexual abuse and the outcome of addiction treatment. American Journal on Addictions, 16: 93-100.
Nowak U, Gill, K, Skamene E, Newkirk MM. (2007) Rheumatoid factor induction in murine models of liver injury. Clinical Experimental Immunology, 147: 324-329.
Margolese, HL, Tempier,R, Negrete JC, Gill K. (2006) A twelve-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance abuse. Schizophrenia Research, 83: 65-75.
Charney, D., Palacios-Boix, J., Negrete, J.C., Dobkin, P.I., Gill, K. (2005) The effects of concurrent depression and anxiety on addiction treatment outcome. Psychiatric Services, 56(8): 927-33.
Gill K., Boyle AEL. (2005) Genetic factors influencing sensitivity to nicotine: A QTL analysis in AcB/BcA recombinant congenic mice. Genes, Brain and Behavior, 4: 401-411.
Gill K., Boyle AEL. (2005) Genetic analysis of alcohol intake in recombinant inbred and congenic strains derived from A/J and C57BL/6J progenitors. Mammalian Genome, 16: 319-31.
Gill K., Boyle AEL. (2005) Quantitative trait loci for an anxiety-related trait in recombinant inbred (RI) and recombinant congenic (RC) strains of mice. Behavioral Brain Research, 161(1): 113-24.
Margolese, HC., Malchy, L., Negrete, JC., Tempier, R., Gill, K. (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research, 67:157-166.
Negrete, JC. (2004) Invited commentary on Green A. et al. “History of alcohol abuse reduces response to antipsychotics in people with first episode psychosis” (Schizophr Res 2004, 66:125-135); Evidence-Based Mental Health, 7(3): 87.
Negrete, JC. Collins, J. Turner, N. Skinner, W. (2004) The CAMH concurrent disorder screener. Canadian Journal of Psychiatry, 49: 843-850.
Silvestri, S., Negrete, JC. Seeman, M. Shammi, CM. Seeman, P. (2004) Does nicotine affect D2 receptor up-regulation?: a case-control study. Acta Psychiatrica Scandinavica,109(4): 312-317.
Other Publications
Gill KJ, Maynard S, Campbell E, Boodhoo K, Gauthier G, Xenocostas S, Charney D, Macaulay AC (2014) Aperçu de deux études sur le programme du gouvernement du Québec pour la prévention, la réduction et le traitement des problèmes de dépendances. L’Intervenant: revue sur la toxicomanie et le jeu excessif 31 (1) : 16-18.
Negrete JC, Gill KJ. (2009) The Aetiology of Alcohol Problems. In: M.G.Gelder, J.J. Lopez Ibor jr., N.C.Andreasen (Eds.) New Oxford Texbook of Psychiatry; Oxford University Press, Oxford (UK), pp 108-112.
Jacobs, J., Gill, K. (2008) Childhood Abuse, Mental Health, and Suicide Attempts in Aboriginal Women. Report prepared for the Native Women’s Shelter of Montreal and other research partners, in collaboration with the National Network for Aboriginal Mental Health Research.
Jacobs, J., Gill, K. (2007) The Lives of Urban Women: A Survey of Help-Seeking Aboriginal and Non-Aboriginal Women in Montreal. Report prepared for the Native Women’s Shelter of Montreal in partnership with the National Network for Aboriginal Mental Health Research.
Negrete, JC. (2007) Introducción. In: N. Szerman, C. Alvarez Vara and M. Casas (Eds.) Patología dual en Esquizofrenia. Glosa, Madrid, pp 19-24.
Negrete, JC. (2005) Screening and Assessing for Concurrent Disorders. In: W.Skinner (Ed.) Treating Concurrent Disorders; a guide for counsellors; CAMH, Toronto, pp 29-84.
Abstracts - Papers Presented at Scientific Meetings
Heath LM, Laporte L, Paris J, Fraser R, Hamdullahpur K, Gill KJ. (August, 2015). Lifetime and Current Factors Influencing Treatment for Borderline Personality Disorder. Poster presented at the Annual Convention of the American Psychological Association, Toronto, Ontario.
Gill K, Hamdullahpur K. A Critical Review of Heroin-Assisted Treatment: Evidence versus Ideology. Paper to be presented at the CCSA "Issues of Substance 2015: Addiction Matters” conference, Montreal, Quebec, November, 2015
Hamdullahpur K, Fraser R, Charney D, Palacios-Boix J, Gill KJ. The Influence of Personality Disorders During Opiate Detoxification: Understanding Treatment Failure. Poster to be presented at the CCSA "Issues of Substance 2015: Addiction Matters” conference, November, 2015.
Maynard, S., Gill K., Cugliandro, A. Implementing frontline screening and early intervention for substance abuse: Does mandated training facilitate change in practice? Poster to be presented at the CCSA "Issues of Substance 2015: Addiction Matters” conference, November, 2015.
Gill KJ, Fraser R. What Clinicians Need to Know About Treating BPD and Addiction. Workshop to be presented at the International Society for the Study of Personality Disorders "Personality Disorders Across the Lifespan” Conference, Montreal, Quebec, October 2015.
Hamdullahpur K, Fraser R, Charney D, Palacios-Boix J, Goulet-Stock S, Maynard S, Heath LM, Gill KJ.Patient Treatment Experience During Detoxification: Understanding the Influence of Personality Disorders. Poster to be presented at the International Society for the Study of Personality Disorders "Personality Disorders Across the Lifespan” Conference, Montreal, Quebec, October 2015.
Heath LM, Laporte L, Paris J, Fraser R, Hamdullahpur K, Gill KJ. (October, 2015). Emotional and Physical Sensitivity in Borderline Personality Disorder: Baseline Characteristics and Treatment Outcomes. Presentation to be given at the International Society for the Study of Personality Disorders "Personality Disorders Across the Lifespan” Conference, Montreal, Quebec, October 2015.
Heath LM, Gill KJ, Laporte L, Paris J, Fraser R, Hamdullahpur K. Lifetime and Current Factors Influencing Treatment for Borderline Personality Disorder. Poster presented at the Annual Convention of the American Psychological Association, Toronto, Ontario, August 2015.
Heath LM, Hamdullahpur K, Fraser R, Charney D, Palacios-Boix J, Gill KJ. Personality Disorders and Addictions Treatment Outcomes. Poster presented at the Early Career Investigators Poster Session on Alcohol and Drug Addiction, sponsored by Divisions 28 & 50/NIAAA/NIDA, at the 2015 American Psychological Association Convention, Toronto, Ontario, August 2015.
Heath LM, Gill KJ, Laporte L, Paris J, Fraser R, Hamdullahpur K. Borderline Personality Disorder: Predictive Factors of Treatment Dropout and Other Outcomes. Poster presented at the 76th Annual Convention of the Canadian Psychological Association, Ottawa, Ontario, June 2015.
Gill K, Heath LM, Torrie J. In Search of Peace of Mind: Mental and Physical Health Among the Cree Peoples of Northern Quebec. Paper to be presented at the Annual Meeting of the National Network for Aboriginal Mental Health, Montreal, Quebec, June 2015.
Gill K. Addiction and Mental Health: Concepts, Measurement and Research Methods. Workshop given at the Annual Meeting of the National Network for Aboriginal Mental Health, Montreal, Quebec, June 2015.
L'Équipe des IRSC - Traitement de la toxicomanie et des maladies mentales: Outils pour les intervenants de première ligne. Le 42e colloque de l'AITQ : Toxicomanie et problématiques associées : agir ensemble. Trois-Rivières, Québec, October 2014. Abstract Accepted April 2014.
Hamdullahpur K, Fraser R, Charney D, Palacios-Boix J, Gill KJ. Illicit and Prescription Opiate Abuse: Understanding Treatment Failure And Improving Outcomes. Paper presented at the CCNP 37th Annual Meeting as part of the Next Generation Symposium, Banff, Alberta, June 2014
Gill K, Low N, Beauclair L, Laporte L. Treatment of Comorbid Substance Dependence and Mental Illness. Paper presented at the NIDA International Forum, Puerto Rico, June 2014.
Gill K, Campbell E, Gauthier G, Charney D, Xenocostas S, Macaulay A, Boodhoo K, and other members of the CIHR Team in Substance Abuse Treatment. Development and Implementation of a “Participant-Driven” Training Program: Preparing Frontline Community Health Workers to Intervene in Substance Abuse. Poster presented at KT Canada Scientific Meeting. Quebec City, Quebec, June 2014.
Campbell E, Gauthier G, Macaulay A, Charney D, Xenocostas S, Gill KJ, and other members of the CIHR Team in Substance Abuse Treatment. Knowledge translation and implementation of frontline screening and early intervention for substance abuse – why are we moving so slowly? Paper presented at Canadian Public Health Association (CPHA) 2014 Annual Conference. Toronto, Ontario, May 2014.
Gill KJ, Gauthier G, Macaulay A, Charney D, Xenocostas S and other members of the CIHR Team in Substance Abuse Treatment. Implementing Frontline Services for Addictions in Quebec: What are the challenges? Poster presented at Canadian Association for Health Services and Policy Research (CAHSPR) Conference 2014. Toronto, Ontario, May 2014.
Campbell E, Gill KJ, Gauthier G, Macaulay A, Charney D, Salsberg J, Xenocostas S, Yuen M, Desrosiers D and the CIHR Team in Substance Abuse Treatment. Developing Evidence-Based Practices for Treating Substance Dependence in Primary Care: Lessons in Knowledge Translation. Canadian Public Health Association (CPHA) 2013 Annual Conference. Ottawa, Ontario, June 2013.
Gill KJ, Gauthier G, Macaulay A, Charney D, Xenocostas S and the CIHR Team in Substance Abuse Treatment. Exploring the Barriers and Facilitators to Knowledge Translation and Implementation of Frontline Services for Substance Abuse. Paper presented at Canadian Association for Health Services and Policy Research (CAHSPR) Conference 2013, Vancouver, British Columbia, May 2013.
Culiandro A, Campbell E, Gauthier G, Charney D, Xenocostas S, Macaulay A, Salsberg J, Yuen M, Desrosiers D, Boodhoo K, Gill K. Knowledge translation in frontline services: Do we know how to train practitioners in screening and early intervention for substance abuse and addictions? Paper presented at Issues of Substance (IOS) 2013, Canadian Centre on Substance Abuse National conference. Ottawa, Ontario, November 2013.
Gill KJ, Campbell E, Gauthier G, Macaulay A, Charney D, Salsberg J, Xenocostas S, Yuen M, Desrosiers D and the CIHR Team in Substance Abuse Treatment. Treating Substance Dependence and Mental Illness - Tools for the Front Line Practitioner. Paper presented at the Primary Healthcare Partnership Forum (PriFor 2012). St. John’s, Newfoundland, November 2012.
Coupland S, Fraser R, Gill KJ. Typologizing Opiate Dependence: Prescription versus Illicit Users. Paper presented at the Department of Psychiatry 22nd Annual Research Day- Dalhousie University, Halifax, November 2012.
Coupland S, Fraser R, Gill KJ. Illicit versus prescription opioid abuse: a comparative analysis of treatment outcomes. Paper presented at Annual Meeting of the Canadian Psychological Association, Halifax, June 2012.
Gill KJ. Scientific Issues in the Treatment of Addiction: Are some harm reduction practices harmful? Paper presented at the Colloquium on Health and Law, Montreal, April 2012.
Coupland, S, Fraser R, Gill KJ. Opiate dependence, chronic pain and personality disorders: Outcome of detoxification. Paper presented at the Annual Meeting of the Canadian Psychological Association, Toronto, June 2011.
Gill, K., Boyle, A.E.L., Shao, Q. Genetic influences on alcohol/drug-related traits in mice. Paper presented at the 7th annual meeting of the Complex Trait Consortium. Montreal, Canada, June 2008
Faridi, K., Gill K. The utility of atypical neuroleptics in substance-use disorders. Paper presented at the annual meeting of the Canadian Psychiatric Association, Toronto 2006
Boyle, A.E., Gill, K. The relationship between anxiety and sensitivity to ethanol in A/J, C57BL/6J and AXB/BXA recombinant inbred strains of mice. Paper presented at the annual meeting of the Research Society on Alcoholism, June 2005.
Zikos, E., Gill, K., Charney, D. Clinical presentation and response to treatment for alcoholism: Impact of Cluster B personality disorders. Paper presented at the annual meeting of the Research Society on Alcoholism, June 2005.
Charney, D., Gill, K. The effects of a lifetime history of sexual abuse on patients entering addiction treatment. Paper presented at the annual meeting of the Research Society on Alcoholism, June 2005.
Zikos, E., Gill, K., Charney, D. The impact of comorbid personality pathology on clinical presentation in a treatment-seeking alcoholic population. Poster presented at the annual meeting of the Canadian Psychiatric Association, October 2004.
Local Knowledge Translation Presentations
Colloque organisé par la Direction du Centre affilié universitaire du CSSS-IUGS (Sherbrooke). Journées de la recherche sociale, Axe de recherche en santé mentale. November 8, 2013. Sherbrooke, Quebec. "Knowledge Translation and Implementation of Frontline Services for Substance Abuse - What have we learned so far?" / "Transfert de connaissances et implantation de services en première ligne en matière de toxicomanie - Qu'avons-nous appris?"
CSSS de la Montagne and the CIHR Team «Journée de réflexion sur les dépendances». Équipe IRSC - Traitement de toxicomanie et problèmes de santé mentale: outils pour les praticiens de première ligne. CSSS de la Montagne, November 2013.
CSSS Cavendish and the CIHR Team «Journée de réflexion sur les dépendances». CIHR Team in Substance Abuse Treatment Treating Substance Dependence and Mental Illness: Tools for the Front Line Practitioner. CSSS Cavendish, September 2012.
CSSS de la Montagne and the CIHR Team «Journée de réflexion sur les dépendances». Équipe IRSC - Traitement de toxicomanie et problèmes de santé mentale: outils pour les praticiens de première ligne. CSSS de la Montagne, April 2012.